vs
Aquestive Therapeutics, Inc.（AQST）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是Aquestive Therapeutics, Inc.的2.0倍（$25.9M vs $13.0M），REDWOOD TRUST INC净利率更高（77.2% vs -244.8%，领先322.0%），Aquestive Therapeutics, Inc.同比增速更快（9.7% vs -6.1%），过去两年Aquestive Therapeutics, Inc.的营收复合增速更高（3.9% vs -41.0%）
Aquestive Therapeutics是一家特种制药企业，专注于中枢神经系统疾病创新疗法的开发与商业化。公司依托专有的药物递送技术打造便于患者使用的治疗方案，服务北美、欧洲市场的医疗机构与患者，核心管线覆盖神经学与精神病学领域的未满足医疗需求。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
AQST vs RWT — 直观对比
营收规模更大
RWT
是对方的2.0倍
$13.0M
营收增速更快
AQST
高出15.8%
-6.1%
净利率更高
RWT
高出322.0%
-244.8%
两年增速更快
AQST
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $25.9M |
| 净利润 | $-31.9M | $20.0M |
| 毛利率 | 55.2% | — |
| 营业利润率 | -221.6% | — |
| 净利率 | -244.8% | 77.2% |
| 营收同比 | 9.7% | -6.1% |
| 净利润同比 | -86.8% | 402.6% |
| 每股收益（稀释后） | $-0.26 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AQSTRWT
| Q4 25 | $13.0M | $25.9M | ||
| Q3 25 | $12.8M | $15.0M | ||
| Q2 25 | $10.0M | $13.8M | ||
| Q1 25 | $8.7M | $27.9M | ||
| Q4 24 | $11.9M | $27.6M | ||
| Q3 24 | $13.5M | $25.5M | ||
| Q2 24 | $20.1M | $67.4M | ||
| Q1 24 | $12.1M | $74.5M |
净利润AQSTRWT
| Q4 25 | $-31.9M | $20.0M | ||
| Q3 25 | $-15.4M | $-7.7M | ||
| Q2 25 | $-13.5M | $-98.5M | ||
| Q1 25 | $-22.9M | $16.1M | ||
| Q4 24 | $-17.1M | $-6.6M | ||
| Q3 24 | $-11.5M | $14.8M | ||
| Q2 24 | $-2.7M | $15.5M | ||
| Q1 24 | $-12.8M | $30.3M |
毛利率AQSTRWT
| Q4 25 | 55.2% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 54.4% | — | ||
| Q1 25 | 58.1% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 67.2% | — | ||
| Q2 24 | 77.5% | — | ||
| Q1 24 | 63.6% | — |
营业利润率AQSTRWT
| Q4 25 | -221.6% | — | ||
| Q3 25 | -89.6% | -9.0% | ||
| Q2 25 | -113.6% | -679.0% | ||
| Q1 25 | -222.1% | 80.2% | ||
| Q4 24 | -114.4% | -1.3% | ||
| Q3 24 | -61.2% | 86.1% | ||
| Q2 24 | 0.3% | 30.3% | ||
| Q1 24 | -74.3% | 41.3% |
净利率AQSTRWT
| Q4 25 | -244.8% | 77.2% | ||
| Q3 25 | -120.6% | -51.4% | ||
| Q2 25 | -135.4% | -712.0% | ||
| Q1 25 | -263.0% | 57.8% | ||
| Q4 24 | -143.7% | -24.0% | ||
| Q3 24 | -85.0% | 58.1% | ||
| Q2 24 | -13.7% | 23.0% | ||
| Q1 24 | -106.4% | 40.6% |
每股收益（稀释后）AQSTRWT
| Q4 25 | $-0.26 | $0.11 | ||
| Q3 25 | $-0.14 | $-0.08 | ||
| Q2 25 | $-0.14 | $-0.76 | ||
| Q1 25 | $-0.24 | $0.10 | ||
| Q4 24 | $-0.18 | $-0.08 | ||
| Q3 24 | $-0.13 | $0.09 | ||
| Q2 24 | $-0.03 | $0.10 | ||
| Q1 24 | $-0.17 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $255.7M |
| 总债务越低越好 | $27.5M | — |
| 股东权益账面价值 | $-33.7M | $982.6M |
| 总资产 | $160.4M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AQSTRWT
| Q4 25 | — | $255.7M | ||
| Q3 25 | $129.1M | $226.3M | ||
| Q2 25 | $60.5M | $302.0M | ||
| Q1 25 | $68.7M | $259.9M | ||
| Q4 24 | $71.5M | $245.2M | ||
| Q3 24 | $77.9M | $253.7M | ||
| Q2 24 | $89.9M | $275.6M | ||
| Q1 24 | $95.2M | $275.4M |
总债务AQSTRWT
| Q4 25 | $27.5M | — | ||
| Q3 25 | $45.0M | — | ||
| Q2 25 | $45.0M | — | ||
| Q1 25 | $45.0M | — | ||
| Q4 24 | $32.5M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $45.0M | $1.7B |
股东权益AQSTRWT
| Q4 25 | $-33.7M | $982.6M | ||
| Q3 25 | $-4.1M | $999.0M | ||
| Q2 25 | $-72.6M | $1.1B | ||
| Q1 25 | $-60.9M | $1.2B | ||
| Q4 24 | $-60.2M | $1.2B | ||
| Q3 24 | $-45.4M | $1.2B | ||
| Q2 24 | $-35.5M | $1.2B | ||
| Q1 24 | $-36.3M | $1.2B |
总资产AQSTRWT
| Q4 25 | $160.4M | $23.7B | ||
| Q3 25 | $163.6M | $22.6B | ||
| Q2 25 | $93.7M | $21.3B | ||
| Q1 25 | $102.2M | $19.9B | ||
| Q4 24 | $101.4M | $18.3B | ||
| Q3 24 | $110.0M | $18.4B | ||
| Q2 24 | $117.6M | $16.5B | ||
| Q1 24 | $129.5M | $15.1B |
负债/权益比AQSTRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $-8.6M | — |
| 自由现金流率自由现金流/营收 | -65.7% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-53.0M | — |
8季度趋势，按日历期对齐
经营现金流AQSTRWT
| Q4 25 | $-8.5M | $-10.1B | ||
| Q3 25 | $-12.6M | $-2.7B | ||
| Q2 25 | $-7.9M | $-2.1B | ||
| Q1 25 | $-23.4M | $-2.0B | ||
| Q4 24 | $-6.5M | $-5.9B | ||
| Q3 24 | $-11.9M | $-2.1B | ||
| Q2 24 | $-7.0M | $-2.0B | ||
| Q1 24 | $-10.4M | $-954.2M |
自由现金流AQSTRWT
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $-12.9M | — | ||
| Q2 25 | $-8.0M | — | ||
| Q1 25 | $-23.5M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $-12.0M | — | ||
| Q2 24 | $-7.0M | — | ||
| Q1 24 | $-10.4M | — |
自由现金流率AQSTRWT
| Q4 25 | -65.7% | — | ||
| Q3 25 | -100.6% | — | ||
| Q2 25 | -80.2% | — | ||
| Q1 25 | -269.9% | — | ||
| Q4 24 | -54.8% | — | ||
| Q3 24 | -88.3% | — | ||
| Q2 24 | -35.0% | — | ||
| Q1 24 | -86.4% | — |
资本支出强度AQSTRWT
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率AQSTRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
